Evidence map›Paper›PMID 28042226›Full record

ArticleOperative techniques in orthopaedics2016

Cell and Biologic-Based Treatment of Flexor Tendon Injuries.

Stephen W Linderman, Richard H Gelberman, Stavros Thomopoulos, Hua Shen

Open access · greenAbstract read
In one paragraph

Article in Operative techniques in orthopaedics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Use of a bioresorbable polylactide sheet (OrthoWrapBMC musculoskeletal disorders · 2025
    Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Proceed with Caution: Mouse Deep Digit Flexor Tendon Injury Model.Plastic and reconstructive surgery. Global open · 2021
    Article
  16. Article
  17. Article
  18. Stem cell-derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Stephen W LindermanDepartment of Orthopaedic Surgery, Washington University, St. Louis, MO, United States; Department of Biomedical Engineering, Washington University, St. Louis, MO, United States.
Richard H GelbermanDepartment of Orthopaedic Surgery, Washington University, St. Louis, MO, United States.
Stavros ThomopoulosDepartment of Orthopaedic Surgery, Columbia University, New York, NY, United States; Department of Biomedical Engineering, Columbia University, New York, NY, United States.
Hua ShenDepartment of Orthopaedic Surgery, Washington University, St. Louis, MO, United States.
Washington University in St. Louis · USColumbia University · US

Funding

The Role of the Osteoblast Secretome in Bone FormationP30AR057235 · NIAMS · WASHINGTON UNIVERSITY · PI ORNITZ, DAVID M · 2009 to 2018
$5.7M
Enhanced Tendon Healing Through Growth Factor and Cell TherapiesR01AR062947 · NIAMS · WASHINGTON UNIVERSITY · PI GELBERMAN, RICHARD H, THOMOPOULOS, STAVROS · 2012 to 2022
$5.5M
Skeletal Disorders Training ProgramT32AR060719 · NIAMS · WASHINGTON UNIVERSITY · PI Roberto Civitelli · 2011 to 2026
$4.6M
Improved orthopaedic repairs through mechanically optimized, adhesive biomaterialsF30AR069491 · NIAMS · WASHINGTON UNIVERSITY · PI LINDERMAN, STEPHEN W · 2016 to 2018
$140k
NIAMS NIH HHS F30 AR069491NIAMS NIH HHS P30 AR057235NIAMS NIH HHS R01 AR062947NIAMS NIH HHS T32 AR060719
6 · The paper itself

Abstract

The two primary factors leading to poor clinical results after intrasynovial tendon repair are adhesion formation within the digital sheath and repair-site elongation and rupture. As the outcomes following modern tendon multi-strand repair and controlled rehabilitation techniques are often unsatisfactory, alternative approaches, such as the application of growth factors and mesenchymal stem cells (MSCs), have become increasingly attractive treatment options. Successful biological therapies require carefully controlled spatiotemporal delivery of cells, growth factors, and biocompatible scaffold matrices in order to simultaneously (1) promote matrix synthesis at the tendon repair site leading to increased biomechanical strength and stiffness and (2) suppress matrix synthesis along the tendon surface and synovial sheath preventing adhesion formation. This review summarizes recent cell and biologic-based experimental treatments for flexor tendon injury, with an emphasis on large animal translational studies.

Indexed as

cellflexor tendon repairgrowth factortissue engineering

Identifiers

PMID28042226
PMCPMC5193226
OpenAlexW2423465182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.